日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MTAP Deletion in Oncogenesis: A Synthetic Lethality Scenario

MTAP缺失在肿瘤发生中的作用:一种合成致死情景

Rodon, Jordi; Johnson, Melissa L; George, Ben; Shah, Pooja A; Arbour, Kathryn C

Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults

健康成人接种MVA-MERS-S疫苗后,MERS-CoV特异性抗体和T细胞反应可持续两年

Mayer, Leonie; Fathi, Anahita; Weichel, Hanna-Marie; Raadsen, Matthijs P; Dahlke, Christine; Mykytyn, Anna; Rodon, Jordi; Gerresheim, Gesche K; Te Marvelde, Merel R; Weskamm, Leonie M; Grewe, Ilka; Schlesner, Claudia; Lütgehetmann, Marc; Drosten, Christian; Becker, Stephan; Haagmans, Bart L; Hardtke, Svenja; Addo, Marylyn M

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity

远程医疗作为早期肿瘤临床试验的途径:来自14000名患者的经验教训以及全球可及性和公平性的未来方向

Torrado, Carlos; Andersen, Clark R; Kang, Lei; Brink, Amanda L; Adesoye, Taiwo; Le, Hung; Patterson, Clover J; Poullard, Anna; Osburn, Jessica A; Tan, Harold N; Gouda, Mohamed A; Charles, Sheena; Urschel, Gabriele E; Tang, Tin-Yun; Hong, David S; Champiat, Stephane; Naing, Aung; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E; Piha-Paul, Sarina A; Rodon, Jordi; Yap, Timothy A; Pohlmann, Paula R; Meric-Bernstam, Funda; Fu, Siqing

Remarkable response of metaplastic breast cancer to a novel targeted AKT inhibitor TAS-117 in a Cowden syndrome patient: a case report

一例考登综合征患者乳腺癌化生症对新型靶向AKT抑制剂TAS-117的显著疗效:病例报告

Godina, Eva; Fernández Carcaño, Marta; Uzunparmak, Burak; Pepper, Thomas; Shah, Pooja; Rodon, Jordi

Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Zenocutuzumab治疗NRG1融合阳性癌症的疗效

Schram, Alison M; Goto, Koichi; Kim, Dong-Wan; Macarulla, Teresa; Hollebecque, Antoine; O'Reilly, Eileen M; Ou, Sai-Hong Ignatius; Rodon, Jordi; Rha, Sun Young; Nishino, Kazumi; Duruisseaux, Michaël; Park, Joon Oh; Neuzillet, Cindy; Liu, Stephen V; Weinberg, Benjamin A; Cleary, James M; Calvo, Emiliano; Umemoto, Kumiko; Nagasaka, Misako; Springfeld, Christoph; Bekaii-Saab, Tanios; O'Kane, Grainne M; Opdam, Frans; Reiss, Kim A; Joe, Andrew K; Wasserman, Ernesto; Stalbovskaya, Viktoriya; Ford, Jim; Adeyemi, Shola; Jain, Lokesh; Jauhari, Shekeab; Drilon, Alexander

Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies

一项针对对标准疗法无效的不可切除的局部晚期或转移性实体瘤患者的sacituzumab tirumotecan 1/2期研究结果

Ouyang, Quchang; Rodon, Jordi; Liang, Yan; Wu, Xinhong; Li, Qun; Song, Lihua; Yan, Min; Tong, Zhongsheng; Liu, YunPeng; Wainberg, Zev A; Wang, Ying; Geng, Cuizhi; Ulahannan, Susanna V; Yu, Guohua; Sharma, Manish R; Wang, Xiang; Wang, Judy S; Spira, Alexander; Zhao, Weihong; Sanborn, Rachel E; Cheng, Ying; Wang, Xian; Liu, Gesha; Li, Yaling; Ge, Junyou; Chartash, Elliot; Akala, Omobolaji O; Yin, Yongmei

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer

USP10/GSK3β介导的PTEN抑制导致乳腺癌对PI3K抑制剂产生耐药性

Kumari, Nishi; Wright, Sarah Ce; Witham, Christopher M; Monserrat, Laia; Palafox, Marta; Richard, John Lc; Costa, Carlotta; Elkabets, Moshe; Agostino, Mark; Klemm, Theresa; Eccles, Melissa; Garnham, Alex; Wu, Ting; Nilsson, Jonas A; Walz, Nikita; Venugopal, Veena; Cerra, Anthony; Vasilevski, Natali; Bridgeman, Stephanie; Bassi, Sona; Saei, Azad; Helal, Moutaz; Neundorf, Philipp; Riedel, Angela; Rosenfeldt, Mathias; Gill, Jespal; Pahor, Nikolett; Hartmann, Oliver; Chung, Jacky; Sidhu, Sachdev S; Moderau, Nina; Jha, Sudhakar; Rodon, Jordi; Diefenbacher, Markus E; Komander, David; Serra, Violeta; Eichhorn, Pieter Johan Adam

A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effects.

vocimagene amiretrorepvec 在晚期实体瘤患者中的 1B 期试验:安全性、肿瘤归巢和免疫调节作用。

Merchan Jaime R, Rodon Jordi, Venkat Shree, Donahue Arthur, Thomassen Amber, Accomando William P, Rodriguez-Aguirre Maria, Kwon Deukwoo, Bentley Cornelia, Hogan Daniel J, Rodrigues Olivia Roos, Yavrom Sharon, Ostertag Derek, Shorr Jolene, Falchook Gerald S

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

帕博利珠单抗联合瘤内注射诺维梭菌-NT治疗晚期实体瘤患者的Ib期研究。

Nelson Blessie Elizabeth, Janku Filip, Fu Siqing, Dumbrava Ecaterina E, Hong David S, Karp Daniel D, Naing Aung, Rodon Jordi, Tsimberidou Apostolia M, Murthy Ravi, Sheth Rahul A, Amaria Rodabe N, Conley Anthony P, Damodaran Senthil, Raghav Kanwal P S, Carapanceanu Nicoleta, Singh Mahendra Pal, Carapanceanu Valentin, Pezeshki Abdulmohammad, Leontovich Alexey A, Kreider Brent L, Tung David, Varterasian Mary, Khazaie Khashayarsha, Piha-Paul Sarina A

Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma

ATR抑制剂camonsertib在一名ALT+转移性黑色素瘤患者中表现出卓越的疗效

Ngoi, Natalie Y L; Silverman, Ian M; Johnson, Adrienne; Meng, Chenfeng; Schonhoft, Joseph D; Zimmermann, Michal; Ulanet, Danielle; Kim, Hyeyeon; Torrado, Carlos; Salguero, Carolina; Brown, Christian Valladolid; Rodon, Jordi; Rimkunas, Victoria; Koehler, Maria; Yap, Timothy A